Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1200963

BIMATOPROST
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CCNC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O

Basic Information

ChEMBL ID CHEMBL1200963
Name BIMATOPROST
Phase Approved
Structure Type MOL
InChI Key AQOKCDNYWBIDND-FTOWTWDKSA-N
Therapeutic ✓ Yes

Known Names

AGN 192024 AGN-192024 Bimatoprost Bimatoprost component of ganfort Durysta Latisse Lumigan Prostamide
2
Targets
2
Activities
1
Assay Types
1
PK Parameters
20
Publications
8
Known Names
10
Indications
1
Mechanisms

Molecular Properties

415.6
MW (Da)
3.15
ALogP
4
HBA
4
HBD
89.8
PSA (Ų)
0.31
QED
0
Ro5 Violations
12
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 2001
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Topical

Flags

Natural Product
USAN Stem -prost
USAN Year 2001

Extended Properties

Molecular Formula C25H37NO4
MW 415.57
Aromatic Rings 1
Heavy Atoms 30
NP-Likeness 1.01

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Prostanoid FP receptor agonist AGONIST Prostaglandin F2-alpha receptor

Indications

Glaucoma Glaucoma, Open-Angle Hypotrichosis Hypotrichosis Ocular Hypertension Graves Ophthalmopathy Alopecia Alopecia Alopecia Areata Vitiligo

ATC Classification

S01EE03
bimatoprost
Level 1: SENSORY ORGANS
Level 2: OPHTHALMOLOGICALS

Activity Summary

IC50 2 meas. best 5.3

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Aldo-keto reductase family 1 member C3
CHEMBL4681
IC50 5.3 5.3 5000.0 1
Bile salt export pump
CHEMBL6020
IC50 4.39 4.39 40400.0 1

Pharmacokinetic Data

Parameter Value Units Species
AUC - ng.hr.mL-1 Homo sapiens

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
22194678 10.1371/journal.pcbi.1002310 Hepatotoxicity 14
- 10.6019/CHEMBL4808148 Histone deacetylase 6 2
37468498 10.1038/s41467-023-40064-9 Muscarinic acetylcholine receptor M2 2
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 1A 2
37468498 10.1038/s41467-023-40064-9 Alpha-1A adrenergic receptor 2
37468498 10.1038/s41467-023-40064-9 Cannabinoid receptor 1 2
37468498 10.1038/s41467-023-40064-9 Gamma-aminobutyric acid receptor subunit alpha-1 2
37468498 10.1038/s41467-023-40064-9 Alpha-2A adrenergic receptor 2
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 2A 2
23956101 10.1093/toxsci/kft176 Homo sapiens 2
37468498 10.1038/s41467-023-40064-9 Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 2
- 10.1101/2020.04.03.023846 SARS-CoV-2 1
32482069 10.1021/acs.jmedchem.9b01033 ADMET 1
37468498 10.1038/s41467-023-40064-9 Voltage-gated inwardly rectifying potassium channel KCNH2 1
37468498 10.1038/s41467-023-40064-9 Glutamate receptor ionotropic, NMDA 1 1
37468498 10.1038/s41467-023-40064-9 Kappa-type opioid receptor 1
23956101 10.1093/toxsci/kft176 ATP-binding cassette sub-family C member 4 1
37468498 10.1038/s41467-023-40064-9 Muscarinic acetylcholine receptor M3 1
37468498 10.1038/s41467-023-40064-9 D(2) dopamine receptor 1
23956101 10.1093/toxsci/kft176 ATP-binding cassette sub-family C member 2 1

Data from ChEMBL 36 via Core Engine